Multifunctional aspartic peptidase prosegments

New Biotechnology

Volumn 25, Issue 5, 2009, Pages 318-324

  Horimoto, Yasumi ^a   Dee, Derek R ^a   Yada, Rickey Y ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC PH; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACTIVE SITE; ALZHEIMER'S DISEASE; ASPARTIC PEPTIDASE; DIRECT IMPACT; FERMENTED FOODS; FOOD APPLICATIONS; HUMAN DISEASE; IN-PROCESS; MOLECULAR MECHANISM; N-TERMINAL; PEPTIDASE INHIBITORS; PH-DEPENDENCE; PROTEIN STABILITY; PROTEOLYTIC CLEAVAGE; STRUCTURE-FUNCTION RELATIONSHIP;

ENZYMES;

PROTEIN FOLDING;

ASPARTIC PEPTIDASE; ENZYME PRECURSOR; PEPSIN A; PEPTIDASE; PLASMEPSIN I; PLASMEPSIN II; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME CONFORMATION; ENZYME INHIBITION; ENZYME MECHANISM; FOOD BIOTECHNOLOGY; HUMAN; HYPERTENSION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN TARGETING; REVIEW;

ANIMALS; ASPARTIC ENDOPEPTIDASES; ENZYME PRECURSORS; HUMANS; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 67349087399     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbt.2009.03.010     Document Type: Review

References (84)

1. Barbano D.M., and Rasmussen R.R. Cheese yield performance of fermentation-produced chymosin and other milk coagulants. J. Dairy Sci. 75 (1992) 1-12
2. Chitpinityol S., and Crabbe M.J.C. Chymosin and aspartic proteinases. Food Chem. 61 (1998) 395-418
3. Kitts D.D., and Weiler K. Bioactive proteins and peptides from food sources. Application of bioprocesses used in isolation and recovery. Curr. Pharm. Des. 9 (2003) 1309-1323
4. Laloi M., et al. Molecular and biochemical characterization of two aspartic proteinases TcAP1 and TcAP2 from Theobroma cacao seeds. Planta 215 (2002) 754-762
5. Ohtani H. Coagulated milk and enzymes. New Food Ind. 30 (1998) 65-79
6. Tomita M., et al. Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem. Cell Biol. 80 (2002) 109-112
7. Cooper J.B. Aspartic proteinases in disease: a structural perspective. Curr. Drug Targets. 3 (2002) 155-173
8. Scott B.B., et al. Development of inhibitors of the aspartyl protease renin for the treatment of hypertension. Curr. Protein Pept. Sci. 7 (2006) 241-254
9. Coombs G.H., et al. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. Trends Parasitol. 17 (2001) 532-537
10. Benes P., et al. Cathepsin D - many functions of aspartic protease. Crit. Rev. Oncol. Hematol. 68 (2008) 12-28
11. Zaidi N., and Kalbacher H. Cathepsin E: a mini review. Biochem. Biophys. Res. Commun. 367 (2008) 517-522
12. Dominguez D.-I., et al. BACE1 and presenilin: two unusual aspartyl proteases involved in Alzheimer's disease. Neurodegener. Dis. 1 (2004) 168-174
13. Vassar R. β-Secretae (BACE) as a drug target for alzheimer's disease. Adv. Drug Deliv. Rev. 54 (2002) 1589-1602
14. Nguyen J.-T., et al. Design of potent aspartic protease inhibitors to treat various diseases. Arch. Pham. Chem. Life Sci. 341 (2008) 523-535
15. Blundell T.L., and Johnson M.S. Catching a common fold. Protein Sci. 2 (1993) 877-883
16. Davies D.R. The structure and function of the aspartic proteinase. Annu. Rev. Biophys. Biophys. Chem. 19 (1990) 189-215
17. Koelsch G., et al. Multiple functions of pro-parts of aspartic proteinase zymogen. FEBS Lett. 343 (1994) 6-10
18. Rawlings N.D., et al. MEROPS: the peptidase database. Nucleic Acid Res. 34 (2006) D270-D272
19. Mutlu A., and Gal S. Plant aspartic proteinases: enzymes on the way to a function. Physiol. Plant. 105 (1999) 569-576
20. Simoes I., and Carlos F. Structure and function of plant aspartic proteinases. Eur. J. Biochem. 271 (2004) 2067-2075
21. Wlodawer A., and Gustchina A. Structural and biochemical studies of retroviral proteases. Biochim. Biophys. Acta. 1477 (2000) 16-34
22. Laudon H., et al. The Alzheimer's diseases-associated γ-secretase complex: functional domains in the presenilin 1 protein. Physiol. Behav. 92 (2007) 115-120
23. Foltmann B. Structure and function of proparts in zymogens for asaprtic proteinases. Biol. Chem. Hoppe-Seyler. 369 Suppl. (1988) 311-314
24. Richter C., et al. Mechanism of activation of the gastric aspartic proteinases: pepsinogen, progastricsin and prochymosin. Biochem. J. 335 (1998) 481-490
25. Bernstein N.K., et al. Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from Plasmodium falciparum. Nat. Struct. Biol. 6 (1999) 32-37
26. Shinde U., and Inouye M. Intramolecular chaperones: polypeptide extensions that modulate protein folding. Semin. Cell Dev. Biol. 11 (2000) 35-44
27. Dunn B.M. Structure and mechanism of the pepsin-like family of aspartic peptidases. Chem. Rev. 102 (2002) 4431-4458
28. Anfinsen C.B. Principles that govern the folding of protein chains. Science 181 (1973) 223-230
29. Kelly J.W. Proteins downhill all the way. Nature 442 (2006) 255-256
30. Baker D., and Agard D.A. Kinetics versus thermodynamics in protein folding. Biochemistry 33 (1994) 7505-7509
31. Baker D., et al. The role of pro regions in protein folding. Curr. Opin. Cell Biol. 5 (1993) 966-970
32. Dee D., et al. Comparison of solution structures and stabilities of native, partially unfolded and partially refolded pepsin. Biochemistry 45 (2006) 13982-13992
33. Dee, D. and Yada, R.Y. The prosegment catalyzes pepsin folding to a kinetically trapped native state, in preparation
34. Parr, C.L. and Yada, R.Y. An investigation of gastoric-like molecular chimeras, in preparation
35. Xiao H., et al. Recombinant expression and partial characterization of an active soluble histo-aspartic protease from Plasmodium falciparum. Protein Expr. Purif. 49 (2006) 88-94
36. Xiao H., et al. Expression and enzymatic characterization of the soluble recombinant plasmepsin I from Plasmodium falciparum. Protein Eng. Des. Sel. 20 (2007) 625-633
37. Sielecki A.R., et al. Molecular and crystal structures of monoclinic porcine pepsin refined at 1.8 Å resolution. J. Mol. Biol. 214 (1990) 143-170
38. James M.N.G., and Sielecki A.R. Molecular structure of an aspartic proteinase zymogen, porcine pepsinogen, at 1.8 Å resolution. Nature 319 (1986) 33-38
39. Hartsuck J.A., et al. The high-resolution crystal structure of porcine pepsinogen. Proteins 13 (1992) 1-25
40. Foltmann B., and Pedersen V.B. Comparison of the primary structures of acidic proteinases and of their zymogens. Adv. Exp. Med. Biol. 95 (1977) 3-22
41. Richter C., et al. Contribution of a prosegment lysine residue to the function and structure of porcine pepsinogen A and its active from pepsin A. Eur. J. Biochem. 261 (1999) 746-752
42. Ahmad F., and McPhie P. The denaturation of covalently inhibited swine pepsin. Int. J. Pept. Protein. Res. 12 (1978) 155-163
43. Privalov P.L., et al. Comparative thermodynamic study of pepsinogen and pepsin structure. J. Mol. Biol. 152 (1981) 445-464
44. Lin X., et al. Conformational instability of the N- and C-terminal lobes of porcine pepsin in neutral and alkaline solutions. Protein Sci. 2 (1993) 1383-1390
45. Konno T., et al. A partially unfolded structure of the alkaline-denatured state of pepsin and its implication for stability of the zymogen-derived protein. Biochemistry 39 (2000) 4182-4190
46. Baker D., et al. A protein-folding reaction under kinetic control. Nature 356 (1992) 263-265
47. Truhlar S.M.E., et al. The folding landscape of Streptomyces griseus protease B reveals the energetic costs and benefits associated with evolving kinetically stability. Protein Sci. 13 (2004) 381-390
48. Derman A.I., and Agard D.A. Two energetically disparate folding pathways of α-lytic protease share a single transition state. Nat. Struct. Biol. 7 (2000) 394-397
49. Jaswal S.S., et al. Comprehensive analysis of protein folding activation thermodynamics reveals a universal behavior violated by kinetically stable proteases. J. Mol. Biol. 347 (2005) 355-366
50. Sohl J.L., et al. Unfolded conformations of α-lytic protease are more stable than its native state. Nature 395 (1998) 817-819
51. van den Hazel H.B., et al. The propeptide is required for in vivo formation of stable active yeast proteinase A and can function even when not covalently linked to the mature region. J. Biol. Chem. 268 (1993) 18002-18007
52. Greenwood B.M., et al. Malaria. Lancet 365 (2005) 1487-1498
53. Mackintosh C.L., et al. Clinical features and pathogenesis of severe malaria. Trends Parasitol. 20 (2004) 597-603
54. Olliaro P.L., and Goldberg D.E. The Plasmodium digestive vacuole: metabolic headquarters and choice drug target. Parasitol. Today 11 (1995) 294-297
55. Ridley R.G. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature 415 (2002) 686-693
56. Berry C., et al. A distinct member of the aspartic proteinase gene family from the human malaria parasite Plasmodium falciparum. FEBS Lett. 447 (1999) 149-154
57. Klemba M., and Goldberg D.E. Characterization of plasmepsin V, a membrane-bound aspartic protease homolog in the endoplasmic reticulum of Plasmodium falciparum. Mol. Biochem. Parasit. 143 (2005) 183-191
58. Asojo O.A., et al. Structures of Ser205 mutant plasmepsins II from Plasmodium falciparum at 1.8 Å in complex with the inhibitors rs367 and rs370. Acta Crystallogr. D Biol. Crystallogr. 58 (2002) 2001-2008
59. Bernstein N.K., et al. Structural insights into the activation of P. vivax plasmepsin. J. Mol. Biol. 329 (2003) 505-524
60. Clemente J.C., et al. Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor. Acta Crystallogr. D. Biol. Crystallogr. 62 (2006) 246-252
61. Madabushi A., et al. Crystallization and preliminary X-ray analysis of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae. Acta Cryst. F61 (2005) 228-231
62. Prade L., et al. X-ray structure of plasmepsin II complexed with a potent achiral inhibitor. J. Biol. Chem. 280 (2005) 23837-23843
63. Bhaumik, P. et al. (2009) Crystal structures of the histo-aspartic protease (HAP) from Plasmodium falciparum. J. Mol. Biol. (Accepted)
64. Hill J., et al. High level expression and characterization of Plasmepsin II, an aspartic proteinase from Plasmodium falciparum. FEBS Lett. 26 (1994) 155-158
65. Silva A.M., et al. Structure and inhibition of plasmepsin II, a hemoglobin-degrading-enzyme from Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 10034-10039
66. Guiterrez-de-Teran H., et al. Inhibitor binding to the Plasmepsin IV aspartic protease from Plasmodium falciparum. Biochemistry 45 (2006) 10529-10541
67. Kim Y.M., et al. Prodomain processing of recombinant plasmepsin II and IV, the aspartic proteases of Plasmodium falciparum, is auto- and trans-catalytic. J. Biochem. 139 (2006) 189-195
68. Conner G.E. The role of the cathepsin D propeptide in sorting to the lysosome. J. Biol. Chem. 267 (1992) 21738-21745
69. Fortenberry S.C., and Chirgwin J.M. The propeptide is nonessential for the expression of human cathepsin D. J. Biol. Chem. 270 (1995) 9778-9782
70. Loll P.J. Membrane protein structural biology: the high throughout challenge. J. Struct. Biol. 142 (2003) 144-153
71. Yasuda Y., et al. The role of the cathepsin E propeptide in correct folding, maturation and sorting to the endosome. J. Biochem. 138 (2005) 621-630
72. Tsukuba T., et al. Characterization of rat cathepsin E and mutants with changed active-site residues and lacking propeptides and N-glycosylation, expressed in human embryonic kidney 293T cells. FEBS J. 273 (2006) 219-229
73. Norman J.A., et al. Stable expression, secretion, and characterization of active human renin in mammalian cells. Mol. Pharmacol. 41 (1992) 53-59
74. Schneider J., and Kent S.B.H. Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-I protease. Cell 54 (1988) 363-368
75. Ohta Y., et al. Pro-peptide as an intermolecular chaperone: renaturation of denatured subtilisin E with a synthetic propeptide. Mol. Microbiol. 5 (1991) 1507-1510
76. Gutierrez-Gonzalez L.H., et al. Loosely packed papain prosegment displays inhibitory activity. Arch. Biochem. Biophys. 446 (2006) 151-160
77. Winther J.S., and Sorensen P. Propeptide of caboxypeptidase Y provides a chaperone-like function as well as inhibition of the enzymatic activity. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 9330-9334
78. Guay J., et al. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides. Eur. J. Biochem. 267 (2000) 6311-6318
79. Cumin F., et al. Inhibition of human renin by synthetic peptides derived from its prosegment. J. Biol. Chem. 260 (1985) 9154-9157
80. Evin G., et al. Synthesis of peptides related to the porsegment of mouse submaxillary gland renin precursor: an approach to renin inhibtors. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 48-52
81. Mercure C., et al. Molecular analysis of human prorenin prosegment vairants in vitro and in vivo. J. Biol. Chem. 270 (1995) 16355-16359
82. Fusek M., et al. Inhibtion of aspartic proteinases by propart peptides of human procathepsin D and chicken pepsinogen. FEBS Lett. 287 (1991) 160-162
83. Dee, D. et al. Production of recombinant prosgment peptide for pepsin folding and inhbition studies, in preparation
84. Daggett V., and Fersht A.R. Is there a unifying mechanism for protein folding?. Trends Biochem. Sci. 28 (2003) 18-25